2025 annual financial data
Neuphoria Therapeutics 2025 Net margin
Neuphoria Therapeutics 2025 net margin with verified reported values.
Direct answer
Net margin was -2.36%.
Operating income was -1,129,091 USD and net income was -369,632 USD.
Operating cash flow was 77,229,000 USD.
Get free Neuphoria Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 15,649,448 USD
- Operating income
- -1,129,091 USD
- Net income
- -369,632 USD
- Operating cash flow
- 77,229,000 USD
Explore related company data
View all 2025 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Neuphoria Therapeutics financial years